Trending...
- Chicago: Mayor Brandon Johnson Celebrates 10-Year Anniversary Of Dyett High School Hunger Strike
- "Leading From Day One: The Essential Guide for New Supervisors" Draws from 25+ Years of International Management Experience
- Prostate Cancer Survivor's Podcast Grows Audience And Builds Marketing Muscle
FAYETTEVILLE, Ark. - illiNews -- Lineus Medical continues to expand the patent protection of its flagship product, SafeBreak Vascular, a break-away medical device technology that helps protect IV lines. The company was awarded United States utility patent US10655768B2 that covers several key features of the device. This is the third patent awarded to Lineus Medical, which now has two utility patents and one design patent pertaining to SafeBreak Vascular.
SafeBreak Vascular is a first of its kind breakaway medical device designed for peripheral IV lines. When a damaging level of force is applied to an IV line, SafeBreak Vascular purposefully separates to minimize the effects of the damaging force and to prevent patient bleeding and the spillage of medication. Vance Clement, CEO of Lineus Medical said, "This issuance of this new utility patent is another important step in adding value to our company and protecting our first product to market, SafeBreak Vascular. The portfolio of patents the company has secured puts the company in a strong intellectual property position to protect and defend its value and SafeBreak Vascular from competition."
More on illi News
Spencer Jones, Chief Technology Officer and Founder of Lineus Medical commented, "We continue to build an intellectual property moat around SafeBreak Vascular, and that moat just became more difficult to overcome. Innovation in product design must be accompanied by meaningful patent protection, and we expect that our issued patents and patents currently under review will further protect our technologies and set-us apart for many years in the market place."
ABOUT LINEUS MEDICAL
Lineus Medical is a developer of medical device technologies that serve the vascular access/IV market. The company develops products that help prevent pain and discomfort in patients, save nurses time and control costs for hospitals. SafeBreak Vascular is not yet FDA cleared and is not yet for sale. More information about Lineus Medical is available at www.lineusmed.com.
MKG-0068 Rev 00
SafeBreak Vascular is a first of its kind breakaway medical device designed for peripheral IV lines. When a damaging level of force is applied to an IV line, SafeBreak Vascular purposefully separates to minimize the effects of the damaging force and to prevent patient bleeding and the spillage of medication. Vance Clement, CEO of Lineus Medical said, "This issuance of this new utility patent is another important step in adding value to our company and protecting our first product to market, SafeBreak Vascular. The portfolio of patents the company has secured puts the company in a strong intellectual property position to protect and defend its value and SafeBreak Vascular from competition."
More on illi News
- Cars.com Names Top EV Picks as Nearly 50% of Shoppers Accelerate Purchases Ahead of Federal EV Tax Credit Expiration Sept. 30 USA - English USA - English
- Open Art Call | The Art of Artificial Intelligence | Copenhagen
- Premieres of 10th Annual NY Dog Film Festival & 8th Annual NY Cat Film Festival on Sunday, October 26, 2025 to Benefit Animal Lighthouse Rescue
- $20 Price Target in Noble Capital Research Report as Deal is Signed for NFL Yearbook Advertising Across 25 Stadiums for AI Powered Sports Leader $SEGG
- 3E Launches First AI Agent Designed to Respond with Empathy for College Recruitment
Spencer Jones, Chief Technology Officer and Founder of Lineus Medical commented, "We continue to build an intellectual property moat around SafeBreak Vascular, and that moat just became more difficult to overcome. Innovation in product design must be accompanied by meaningful patent protection, and we expect that our issued patents and patents currently under review will further protect our technologies and set-us apart for many years in the market place."
ABOUT LINEUS MEDICAL
Lineus Medical is a developer of medical device technologies that serve the vascular access/IV market. The company develops products that help prevent pain and discomfort in patients, save nurses time and control costs for hospitals. SafeBreak Vascular is not yet FDA cleared and is not yet for sale. More information about Lineus Medical is available at www.lineusmed.com.
MKG-0068 Rev 00
Source: Lineus Medical
0 Comments
Latest on illi News
- TSWHZC Platform Combines Automated Portfolio Management with Proof of Reserves for Brazil Market Entry
- AureaVault Positions Digital Asset Infrastructure for Shifting Monetary Policy Environment
- JQRBT Unveils High-Speed Trading Infrastructure Designed for Growing Institutional Crypto Market
- New Leadership and Renovations Usher in Next Chapter for Sunrise Manor
- Who Will Win the 2025 WNBA Finals? OddsTrader Shares Live Betting Odds and Projections
- Naperville's Annual Public Safety Open House Set for Sept. 27
- Geeks5g Creative Marketing: The Powerhouse Behind Business Growth
- Agemin Unveils Breakthrough AI Model for Biometric Age Estimation, Setting New Standards in Online Child Safety
- Chicago: O'Hare International Airport Sets All-Time Passenger Record in July 2025
- The Hidden Triggers of Foreclosure Most Families Don't See Coming
- Strategic Partnerships with Defiant Space Corp and Emtel Energy USA Powerfully Enhance Solar Tech Leader with NASA Agreements: Ascent Solar $ASTI
- 120% Revenue Surge with Four Straight Profitable Quarters Signal a Breakout in the Multi-Billion Dollar Homebuilding Market: Innovative Designs $IVDN
- Leading Venture Capital Firms Recognize Wzzph Exchange's Technical Architecture and Security Framework as Industry Benchmark
- DivX Unveils Major DivX Software Update: Seamless Video Sharing and Customizable Playback Now Available
- Nespolo Mechanical Helps New Mexico Families Save Thousands on Heating Costs This Fall
- Leading Digital Finance Platform YNQTL Launches Revolutionary Web3 Digital Asset Trading Platform
- IDCXS Addresses Crypto Trading Pain Points with 2 Million TPS Processing and Multi-Layer Security Architecture
- Bridging Traditional Finance and Web3 Innovation: BLFCW Announces Strategic Vision for Regulated Web3 Economy
- NKSCX Responds to "Coordinated Smear Campaign" as Anonymous Critics Emerge Following Regulatory Milestones
- Broadway Gala Honored Also an Italian